Literature DB >> 19562263

[Cerebrovascular diseases].

P J Kuhlencordt1, J Röling, U Hoffmann.   

Abstract

In the majority of the cases cerebrovascular disease is caused by atherosclerosis. Duplexsonography is the diagnostic tool of first choice. Management of cardiovascular risk factors is of paramount importance in secondary prevention of atherosclerotic vascular complications. Patients with a symptomatic internal carotid artery stenosis >70% have a clear indication for revascularization. Asymptomatic patients with >60% stenosis benefit from revascularisation if the perioperative risk for death or stroke is below 3%. The optimal revascularization strategy highly depends on the expertise of the local surgeon or endovascular specialist. In younger patients with cerebrovascular disease rare causes such as dissection, large vessel arteritis, fibromuscular dysplasia or vasospasms have to be considered.

Entities:  

Mesh:

Year:  2009        PMID: 19562263     DOI: 10.1007/s00108-009-2367-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

2.  ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting).

Authors:  Eric R Bates; Joseph D Babb; Donald E Casey; Christopher U Cates; Gary R Duckwiler; Ted E Feldman; William A Gray; Kenneth Ouriel; Eric D Peterson; Kenneth Rosenfield; John H Rundback; Robert D Safian; Michael A Sloan; Christopher J White
Journal:  J Am Coll Cardiol       Date:  2007-01-02       Impact factor: 24.094

3.  [Interventional treatment of extracranial carotid stenoses: current status, requirements and indications].

Authors:  H Mudra; W Büchele; K Mathias; G Schuler; H Sievert; W Theiss
Journal:  Vasa       Date:  2006-05       Impact factor: 1.961

4.  Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease.

Authors:  C P Derdeyn; W J Powers
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

5.  Angioplasty and stenting for total symptomatic atherosclerotic occlusion of the subclavian or innominate arteries.

Authors:  A González; A Gil-Peralta; J R González-Marcos; A Mayol
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

6.  Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase.

Authors:  Robert W Hobson; Virginia J Howard; Gary S Roubin; Thomas G Brott; Robert D Ferguson; Jeffrey J Popma; Darlene L Graham; George Howard
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

7.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

8.  Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study.

Authors:  P P Mineva; I C Manchev; D I Hadjiev
Journal:  Eur J Neurol       Date:  2002-07       Impact factor: 6.089

Review 9.  Randomized controlled trials comparing endarterectomy and endovascular treatment for carotid artery stenosis: a Cochrane systematic review.

Authors:  Jörg Ederle; Roland L Featherstone; Martin M Brown
Journal:  Stroke       Date:  2009-02-19       Impact factor: 7.914

10.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Authors:  Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  Lancet Neurol       Date:  2008-08-29       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.